Information Provided By:
Fly News Breaks for August 6, 2018
SRDX
Aug 6, 2018 | 16:03 EDT
Lake Street analyst Brooks O'Neil raised his price target for Surmodics to $90 citing the company's "solid" Q3 results and raised guidance for fiscal 2018. The analyst says that while core businesses are gems, he's most excited about the future opportunities for Surmodics. The company is "clearly making progress" on at least 15 510 (k) products to launch over the next several years, O'Neil tells investors in a research note. He affirms a Buy rating on the shares.
News For SRDX From the Last 2 Days
There are no results for your query SRDX